XFOR
X4 Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$381.05M
P/E Ratio
—
EPS
$-2.07
Beta
0.32
52W High
$4.83
52W Low
$1.35
50-Day MA
$4.11
200-Day MA
$3.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About X4 Pharmaceuticals Inc
X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for the treatment of back diseases. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $9.01M |
| Gross Profit (TTM) | $7.38M |
| EBITDA | $-89.69M |
| Operating Margin | -748.00% |
| Return on Equity | -104.20% |
| Return on Assets | -28.30% |
| Revenue/Share (TTM) | $0.13 |
| Book Value | $1.79 |
| Price-to-Book | 2.25 |
| Price-to-Sales (TTM) | 42.27 |
| EV/Revenue | 24.76 |
| EV/EBITDA | 1.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -90.60% |
| Shares Outstanding | $94.32M |
| Float | $57.41M |
| % Insiders | 0.61% |
| % Institutions | 99.59% |
Historical Volatility
HV 10-Day
65.91%
HV 20-Day
53.49%
HV 30-Day
53.36%
HV 60-Day
82.19%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.67 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026